Menu

Artificial intelligence in pharmaceutical development and manufacturing

Articles 7 June 2023

The application cases of artificial intelligence to the pharmaceutical sector are vast. Besides its accessibility and simplicity of use, artificial intelligence has significant advantages: less variability in test results, less verification activity in the case of a validated system, improved process knowledge… Chat GPT is in itself a good example of the advantages that AI may bring to the sector.

Cécile Théard-Jallu, partner, and Grégoire Froussart, associate, wrote an insight on the topic, released in the latest edition of PharmaNetwork.

Read article

Authors

Cécile
Théard-Jallu
Partner
Grégoire
Froussart
Lawyer - Senior
Would you like to be kept up to date with the latest news on this topic?
Sign up to receive e-mails of new articles, events, analysis... on the subjects most relevant to you.
Create your customized watch

Receive news on the topics
that matter to you

Further information

Discover our professionals

Serge
Lederman
Partner
Cécile
Théard-Jallu
Partner
Charlotte
Hébert-Salomon
Partner
annemarechal
Anne
Maréchal
Partner

Latest news

arrivée-christian-leroux
Firm Life 20 October 2026
Christian Le Roux joins De Gaulle Fleurance as Of Counsel, responsible for development strategy
Tuesday, November 3, 2026 – 5:00 PM (CET)
Events webinar
03/11/202617h00
Europrivacy : GDPR Certification Now Available to Organisations Outside the EU
Epopée Gestion Enervivo
Articles 13 October 2026
De Gaulle Fleurance Assists Épopée Gestion and Enervivo in Investing in the Creation of a Platform Dedicated to Biomethane
Awards
Décideurs
De Gaulle Fleurance recognised in the 2026 Décideurs – Leaders League ranking for Healthcare, Pharma & Biotech